1 |
马晓, 马英桓. 血液透析和腹膜透析治疗终末期糖尿病肾病临床疗效的Meta分析 [J]. 临床内科杂志, 2021, 38(10): 682-686.
|
2 |
Brown EA, Zhao J, McCullough K, et al. Burden of kidney disease, health-related quality of life, and employment among patients receiving peritoneal dialysis and in-Center hemodialysis: findings from the DOPPS program [J]. Am J Kidney Dis, 2021, 78(4): 489-500.
|
3 |
杨彦平, 李海燕, 刘国. 腹膜透析与高通量血液透析对老年终末期肾病患者氧化应激水平及细胞免疫功能的影响 [J]. 中国现代医学杂志, 2020, 30(16): 77-80.
|
4 |
Chen L, Chen G, Kong X. Serum level of high mobility group box protein-1 and prognosis of patients with end-stage renal disease on hemodialysis and peritoneal dialysis [J]. Medicine (Baltimore), 2021, 100(5): e24275.
|
5 |
Chen ST, Yao Y, Tseng YS, et al. Developing a theory to help guide end-stage renal disease patients to adapt to peritoneal dialysis: A grounded theory study [J]. J Clin Nurs, 2022, 31(1-2): 134-144.
|
6 |
上海慢性肾脏病早发现及规范化诊治与示范项目专家组. 慢性肾脏病筛查诊断及防治指南 [J]. 中国实用内科杂志, 2017, 37(1): 28-34.
|
7 |
Al Sahlawi M, Zhao J, McCullough K, et al. Variation in peritoneal dialysis-related peritonitis outcomes in the peritoneal dialysis outcomes and practice patterns study (PDOPPS) [J]. Am J Kidney Dis, 2022, 79(1): 45-55.
|
8 |
Choi HS, Han KD, Oh TR, et al. Trends in the incidence and prevalence of end-stage renal disease with hemodialysis in entire Korean population: A nationwide population-based study [J]. Medicine (Baltimore), 2021, 100(13): e25293.
|
9 |
Rostoker G, Issad B, Fessi H, et al. Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective [J]. J Nephrol, 2021, 34(4): 985-989.
|
10 |
Yan H, Abreu Z, Bargman JM. Incremental peritoneal dialysis in incident end-stage kidney disease patients [J]. Perit Dial Int, 2022, 42(4): 387-393.
|
11 |
Tang M, Fan JX, Fang JG, et al. Risk factors of cardiac complications in patients with end-stage renal disease undergoing maintenance peritoneal dialysis [J]. Ann Palliat Med, 2022, 11(7): 2196-2201.
|
12 |
Iseri K, Qureshi AR, Ripsweden J, et al. Sparing effect of peritoneal dialysis vs hemodialysis on BMD changes and its impact on mortality [J]. J Bone Miner Metab, 2021, 39(2): 260-269.
|
13 |
Chrifi Alaoui A, Touti W, Al Borgi Y, et al. Comparison of quality of life in end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis in a Moroccan city [J]. Semin Dial, 2022, 35(1): 50-57.
|
14 |
Yildirim M, Acikgoz SB, Genc AB, et al. The levels of inflammatory biomarkers in hemodialysis and peritoneal dialysis patients [J]. Rev Assoc Med Bras (1992), 2021, 67(5): 718-723.
|
15 |
Wu H, Zhou H, Zhang Q, et al. Systematic review and meta-analysis: the effect and safety of peritoneal dialysis in patients with end-stage diabetic kidney disease [J]. Ann Palliat Med, 2022, 11(2): 695-707.
|
16 |
Ng CH, Ong ZH, Sran HK, et al. Comparison of cardiovascular mortality in hemodialysis versus peritoneal dialysis [J]. Int Urol Nephrol, 2021, 53(7): 1363-1371.
|
17 |
Csiky B, Sági B, Emmert V, et al. Cardiometabolic effects of Irisin in patients with end-stage renal disease on regular hemo- or peritoneal dialysis [J]. Blood Purif, 2022, 51(5): 450-457.
|
18 |
朱琼, 韩久怀, 吴玲燕, 等. 低钙血液透析与低钙腹膜透析对尿毒症患者钙磷代谢及颈动脉钙化的影响 [J]. 中国医师杂志, 2022, 24(4): 598-600.
|
19 |
Sampani E, Stangou M, Daikidou DV, et al. Influence of end stage renal disease on CD28 expression and T-cell immunity [J]. Nephrology (Carlton), 2021, 26(2): 185-196.
|
20 |
Zou M, Xie J, Lan L, et al. Safety and efficacy of hemodialysis and peritoneal dialysis in treating end-stage diabetic nephropathy: a meta-analysis of randomized controlled trials [J]. Int Urol Nephrol, 2022, 54(11): 2901-2909.
|